Sahin Boydas
Random theme
Select theme
Back to all articles

The 5 Unspoken Rules of Building a Defensible AI Moat in Biotech

I've got the scar tissue to prove it. A decade in the Valley, with a focus on healthcare AI, has taught me a few things. Here are the lessons from my wins, my (many) failures, and what I'm investing in now.

2024-12-175 min read548 words

I've got the scar tissue to prove it. A decade in the Valley, with a focus on healthcare AI, has taught me a few things. Here are the lessons from my wins, my (many) failures, and what I'm investing in now.

The Reality Nobody Talks About

A lot of the advice on biotech AI rests on assumptions that made sense five years ago. The world has moved on.

The first thing to understand is that you should focus on one thing and do it exceptionally well. I've seen this play out across dozens of companies. The pattern is unmistakable.

Many teams spend months on the wrong path before realizing that the best solutions are often the simplest ones. Once they make the switch, everything changes.

What I've Learned From 116 Companies

A few patterns in biotech AI come up again and again.

The founders who handle biotech AI well understand that you need to move fast and break things.

The AI Angle

Any discussion of biotech AI in 2026 has to include AI. As someone who's invested in Anthropic, OpenAI, Scale AI, and Hugging Face, I have a front-row seat to how AI is transforming this space.

The short version: AI makes good practitioners better and bad practitioners worse. It's an amplifier, not a replacement.

Some teams use AI to get far more out of biotech AI. Others spend heavily on AI that solves the wrong problem. The difference comes down to understanding what you're actually trying to achieve.

This connects to broader themes around AI diagnostics, AI mental health, AI radiology, medical AI, healthcare automation that I've been thinking about a lot lately.

Wrapping Up

I've shared a lot here, and I know it can feel overwhelming. But you don't need to get biotech AI right on day one. You just need to get started and keep improving.

Founders who do well at biotech AI tend to share one trait: they're relentlessly practical. They don't chase perfection. They chase progress.

That's the mindset I'd encourage you to adopt. Start where you are. Use what you have. Do what you can. And keep pushing forward.

As always, I'm rooting for you.

FAQ

Frequently Asked Questions

Q:How has this view evolved over time?

My thinking on most topics has changed significantly over the years. Early in my career, I held many conventional views that experience proved wrong. I try to update my beliefs when the evidence changes.

Q:How can I apply this thinking to my own situation?

Start by identifying the core principle behind the opinion, not the specific example. Then ask yourself: does this principle apply to my context? If yes, test it in a small, low-risk way before going all in.

Q:What's the most common pushback you get on this?

People often push back by citing exceptions or edge cases. And they're usually right that exceptions exist. But building a strategy around exceptions rather than patterns is a losing game for most founders.

Q:What experience informs this perspective?

This perspective comes from over a decade of building companies in Silicon Valley, two successful exits (RemoteTeam to Gusto, MovieLaLa to Gfycat), and investing in 234 startups including Anthropic, OpenAI, and Scale AI. I write about what I've lived.

Written by

Sahin Boydas

Serial entrepreneur, #1 angel investor, author of Becoming Top 1%

Get Sahin's Weekly Insights

Join 10,000+ founders and investors. One email per week with actionable advice on startups, investing, and building in the AI era.

No spam. Unsubscribe anytime.